newsfilter
← Latest News
PR Newswire·

Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

Novel serotonergic agonists ("NSAs") are quickly becoming one of the more interesting stories in mental-health and neuroscience investing. In simple...